I'm living in Europe and just started buying stocks. I'm mostly interested in innovative companies fx. Stellar, Natcore etc and also companies, which are in a future rapid growth sector fx robotics etc. I am sorry that my English is not perfect.
Dabbling here and there while in school working on a Computer Science degree from OSU. First degree was in Science from PSU. I enjoy the challenge investing has to offer. My main focus is on companies in the OTC market. Main sectors of interest: marijuana, robotics, biotechnology and pharm. / med. The scientist a great story about the grandfather of cannabis research Dr Mechoulam:https://www.youtube.com/watch?v=PWabJ6DS55Q (a documentary I find greatly informative and a good watch IMHO.)
iHub membership: Bluesummers (if you see snoopy in the rain and a red dog house - that's me).
OTC stocks I'm currently looking at / watching:
ELTP (anti-abuse pain medication; with ideal design behind them),
TRTC (medical / rec. marijuana products),
ASTI (solar portable products),
LMRMF (graphene supplier and manufacturer),
GPHBF (graphene 3D printing - partially owned by LMRMF), and
SFOR (key encryption software).
Non OTC stocks (mostly for capital preservation / portfolio diversification):
TWMJF (CAN marijuana),
OGI (CAN medical marijuana),
LEU (enriched uranium supplier),
SCTY (solar panels),
EBS (anthrax vaccine - only one approved by FDA),
PSTI (stromal cells for commercial use in disease treatment),
WTI (oil and gas Gulf of Mexico),
BADFF (CAN hydrovac excavation; costumer base: 51% oil and gas and 49% utility and municipality), and
BNO (oil fund).
Invested in: ELTP and LEU.
Watching: TRTC, TWMJF, GPHBF, and SFOR.
On my smartphone:
Retired Refinery and Petrochemical Commissioning and Production Manager, having worked for 48 years worldwide in more than 42 countries and on more than 42 small and big projects. Fluent in at least 4 languages and a practical very Hands-on Engineer / peoples Leader and so on. Now staying in Switzerland on a Refinery Project.
I primarily invest based on knowledge of technology, and rarely if ever try to time stocks.
The only way I've been effective investing is by understanding the technology behind the products a company sells, and the market they sell in, while being dispassionate and unbiased.
Professional investor and overall good guy.
By reading Mako Research reports, you agree to use the information at your own risk. In no event should Mako Research or any affiliated party be liable for any direct or indirect trading losses caused by information contained in the research reports. Research reports are not investment advice or a recommendation or solicitation to transact any securities. Mako Research is not a registered investment advisor. You agree to do your own research and due diligence before making any investment decision with respect to securities covered herein. You should assume that Mako Research stands to profit in the event the issuer’s stock declines. Research reports may contain opinions, which are based upon generally available public information, field research, inferences and deductions through due diligence and analytical processes. All information is believed to be accurate and reliable, and has been obtained from public sources. Mako Research makes no representation, express or implied, as to the accuracy, timeliness, or completeness of any such information. All expressions of opinion are subject to change without notice, and Mako Research is not obligated to update or supplement any reports or any of the information, analysis and opinion contained in them. You should assume that Mako Research has and/or will submit findings with the Securities Exchange Commission, and other entities that may find the information useful.
I like to look for situations where I think the market is not accurately reflecting the true fundamentals of a company. I buy all my ideas in my own account before writing about them, so investors should be aware of this. I will also sell them before telling others, so, once again, please keep this in mind if you're following my ideas.
Dr. Robert N. Castellano, president of The Information Network (http://www.theinformationnet.com/), received a Ph.D. degree in solid state chemistry from Oxford University (England). He has had ten years experience in the field of wafer fabrication at AT&T Bell Laboratories and Stanford University. He has authored numerous reports for other publishing companies before founding The Information Network in 1985. He has been editor of the peer-reviewed Journal of Active and Passive Electronic Devices since 1985. He writes a monthly column in “Vacuum Technology & Coating” magazine and “Wafer & Device Packaging Interconnect” magazine. He is author of the book "Technology Trends in VLSI Manufacturing" published by Gordon and Breach. He is also a Senior Contributor to TheStreet.com. His book "Solar Panel Processing" was published in 2009 by Old City Publishing. His latest book, "Alternative Energy Technology" was published in 2012. Also in the solar area, he is CEO of SolarPA, which uses a proprietary nanomaterial to coat solar cells, increasing the efficiency by up to 10%. He had been on the Advisory Board of Principal Solar. He recently published a fictional novel Blessed, available on Amazon and other sites.
Well what about me. I retired in Oct. of 2011 at the age of 56. Retirement came from two avenues, 1) I was a Mechanical Engineer in the past, ended up in Vegas building large Casino Projects as Lead ME. At the time, the bonus structures were very good and I invested most. 2) my oldest son started, built and then sold a very successful and profitable computer game company. Together, this allowed us to purchase a small ranch/farm in the Pacific Northwest where I raise Arabian Horses and I am starting a Sustainable Beef Cattle Business. I consider myself a "Latent Cowboy". My Family backround was in Ranching when I was a child.
I spend most my time ranching (in the building phase right now) plus I also manage my portfolio. I had substantial cash from bonuses and some gaming winnings at the the time of the crash. This allowed me to purchase a number of very solid stocks at rock bottom prices, some of which I still hold and others that I have turned.
I tend to invest in things I know, use my common sense and do massive amounts of home work. Lately, I have been shifting my holdings a away from a more dividend based mix to growth stocks. I use about 40% of the base for higher risk stocks to keep things interesting.
Gregory Pepin is a co-partner of a Wealth Management company in switzerland. He has a Master of Science degree in Finance and Actuary Science from HEC Lausanne (Switzerland). He also teaches Finance at the University of St. Joseph (Lebanon).
Gregory is a strong believer of the Graham Theory that advises to invest for the long term based on fundamentals. He applies this strategy for his own portfolio and all of the funds he manages for customers in his wealth management company.
Mr. A. Paul Gill has been the CEO of Lomiko Metals Inc. TSXV: LMR, OTC: LMRMF since June 2009 and CEO of Lomiko Technologies private) since 2014. Mr. Gill developed significant experience in the strategic development of resource companies such as Norsemont Mining,Inc. (Bought by HudBay Minerals for $ 512 million). He has held the positions of President, Chief Financial Officer, Corporate Secretary and Vice-President of Business Development of Norsemont Mining Inc. and served as a co-founding director. Mr. Gill has been a Consultant of AJS Management private) since March, 2001 and a Director with Graphene 3D Lab TSXV: GGG, OTC: GPHBF, Graphene ESD and Epic Mining Corp.
We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices. It is our unwavering commitment to connect the investment community with companies that have great potential and a strong dedication to building shareholder value.
View our website at www.MissionIR.com
MissionIR provides investor relations services to publicly traded companies in exchange for compensation. The content we provide via Seeking Alpha may be part of our efforts to widen a client’s exposure. To read our full disclaimer, visit http://disclaimer.missionir.com.
Founder of Disruptive Tech Research – a technology research and advisory firm serving the investment management community.
We provide registered investment professionals and qualified firms with independent, targeted research to support the generation of investment ideas.
We focus on patent-filing activity to identify the most promising disruptive technology trends early. Then, we employ an original, bottom-up fundamental research approach to uncover micro- and small-cap ideas that are underfollowed, underappreciated and undervalued.
Our mission is to provide clients with differentiated, actionable and thorough fundamental research at a cost effective price.
We’re 100% independent. That means absolutely no pay-to-play arrangements, no hidden agendas and no hype. Just solid research. And yes, we eat our own cooking.
I started my investment career at Morgan Stanley, where I helped direct over $1 billion in in institutional capital. After growing bored with the monotony of asset allocation studies, investment policy statements, manager searches and evaluations, and Retirement Plan Service Provider RFPs (among other things), I left and co-founded Wall Street Daily, which quickly became one of the web’s largest financial publishers with a daily circulation of more than 700,000 readers.
In 2014, I founded Disruptive Tech Research to pursue my investing passion, and fill the void in the market for high-quality, 100% independent research on disruptive technologies.
I have been fortunate to appear regularly on CNBC’s Closing Bell, as well as be mentioned in other media outlets, including in The Wall Street Journal, The New York Times, Morningstar and MarketWatch. I earned my MBA from the Crummer Graduate School of Business at Rollins College, which is also where I met my beautiful wife.
Pro Deo, Pro Familia, Pro Patria
As an avid stock trader I am always searching for new opportunities. I utilize a very research heavy approach in my strategy that has done quite well for me over the years. I have earned a degree in Physics and an MBA in Finance. Although my educational background is an unconventional pairing, both have served me well. I am currently a consultant that specializes in small business development.
Active investor and trader since my teens. I retired early from my career in healthcare administration and have been a full time investor for 5 years.
I write about 3D Printing Stocks on my site @ 3DPrintingStocks.com, as well as small and microcap stocks (no pinks or junk!) at MicrocapResearch.com
I am Chirag Shah. I have a Masters degree in Pharmacy. Pharma and Biotech are my passion. I am an opportunistic investor. Currently I am working with a growing generic drug development company as a pharmaceutical formulation scientist.
KLLJ is a private investor focusing on small cap stocks in biotechnology, emerging markets and renewable energy. I have been an active investor for 15 years and focus on picking stocks with tremendous upside. I enjoy sharing my thoughts in forums such as Seeking Alpha to help with my own due diligence process. I'm a critical thinker who appreciated constructive feedback to my investing ideas. I am not a short-term or momentum trader and like to think my strength is in picking good stocks with 10X potential returns. I don't believe in relying on Wall Street coverage of companies because of the inherent conflicts of interest (known or unknown.) We are in the market to make money and it is up to you, the individual retail investor to perform your own analysis for investment decisions if you want to win in the market. My analysis and viewpoints are not investment advice and you should always perform your own due diligence.
Financial entrepreneur in China. Managing Director of an FX brokerage firm based in Shanghai. Also running a Cayman long equities fund investing in Chinese equities through the HKSE. We are tremendously long term bullish on Chinese equities.
I have an insatiable desire to learn and I believe there are so many intelligent contributors on SA to learn from. My passion is to build a lifetime following from my clients. It's not about the money; it's about building legacies, fulfilling dreams, achieving and maintaining the lifestyles we aspire for.
We are a research group that consults hedge fund and high-net worth clients. We specialized in identifying special opportunities from both the long and short side. The writer for 3D Analytics has professional traded for hedge funds for 10+ years and specializes in 1) finding hidden, unrecognized value, 2) shorting overvalued stocks, and 3) arbitrage situations. The articles are written solely by him, but has a group that assist him in finding opportunities, basic research, and editing.
Curis, Inc. (CRIS) - NasdaqGM rated best investment going forward in Biotech for the remainder of 2014 and certainly for 2015.
Past Results - Achillion Pharmaceuticals, Inc. (ACHN) was issued a best investment rating on April 14, 2014 and it's hoped that on June 16, 2014 that investors locked in profit near the highs. The high that day was $8.05. The best investment rating was issued from the $2.70's area.
Athersys, Inc. (ATHX) - NasdaqCM In 2013 ATHX in the $1.60's area was issued a best investment notice. Followed up with several articles pointing out its potential. It's hoped investors took profit over $4 in early 2014. Today ATHX and its MultiStem is of high risk with one "no efficacy" phase II trial in 2014 reporting. For this reason ATHX is a buy only under $1.60 again today. This will limit downside to some degree if MultiStem fails again to show efficacy in a second phase II trial.
Other past calls were CLDX, ACUR and ALNY.
Highly educated private investor with 35 years experience investing in individual stocks and an occasional ETF. I particularly like disruptive technology and growth stocks that are undervalued or beaten down.